TARA — Protara Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $42.83m
- -$12.40m
- 27
- 41
- 60
- 38
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.18 | 169 | 91.2 | 84.4 | 65.6 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | — | 0.486 | 0.242 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 6.97 | 169 | 93.1 | 86.1 | 68.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | 2.3 | 8.89 | 7.87 | 6.56 |
Net Goodwill | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 6.97 | 203 | 173 | 113 | 79 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.583 | 2.92 | 4.3 | 5.74 | 6.15 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.583 | 3.91 | 10.7 | 11.2 | 10.6 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 6.39 | 199 | 162 | 102 | 68.3 |
Total Liabilities & Shareholders' Equity | 6.97 | 203 | 173 | 113 | 79 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |